MedTrace Logo

Efficacy of the Chronic Application of Tear Formulations

NCT01384851 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2011-07-01

No results posted yet for this study

Summary

The purpose of this study is to determine the therapeutic effect of the chronic application of eye-drops on tear evaporation rate in dry eye and normal subjects exposed to a condition of environmental stress. The effect will be studied in terms of changes in tear physiology and the inflammatory biomarkers on the ocular surface.

Conditions

  • Dry Eye

Interventions

DRUG

Next Generation Emulsion

One drop both eyes 4 times daily for two weeks

DRUG

Refresh Dry Eye Therapy

One drop both eyes four times daily for two weeks

DRUG

Refresh Contacts

One drop both eyes four times daily for two weeks

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Glasgow Caledonian University

    lead OTHER

Principal Investigators

  • Alan Tomlinson, DSc PhD · Glasgow Caledonian University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01384851 on ClinicalTrials.gov